| 000 | 01894nam a2200349 4500 | ||
|---|---|---|---|
| 001 | 394298 | ||
| 010 | _a9789284613473 | ||
| 090 | _a394298 | ||
| 100 | _a20161221d2016 y0pory50 ba | ||
| 101 | _aeng | ||
| 200 |
_aA review and assessment of EU drug policy _bRecurso eletrónico _estudy _fMirja Gutheil ...[et al.] |
||
| 210 |
_aBrussels _cEuropean Parliament. Policy Department for Citizen's Rights and Constitutional Affairs _d2016 |
||
| 215 |
_a1 CD-ROM _d12 cm |
||
| 300 | _aFicheiro de 2,41 MB em formato PDF (224 p.). | ||
| 330 | _aExecutive Summary. 1. Introduction and Methodology. 2. International Drug Policy Overview. 3. Eu Legal and Policy Framework. 4. Member State Drug Policies. 5. Effectiveness and Added Value of Drug Policy. 6. Observations, Recommendations and Policy Proposals. References. Appendix A: Eu Case Studies. Appendix A1: Case Study – Czech Republic. Appendix A2: Case Study – Germany. Appendix A3: Case Study – Spain. Appendix A4: Case Study – Netherlands. Appendix A5: Case Study – Poland. Appendix A6: Case Study – Portugal. Appendix A7: Case Study – Sweden. Appendix B: Non-Eu Case Studies. Appendix B1: Case Study – Switzerland. Appendix B2: Case Study – United States Of America. Appendix B3: Case Study – Uruguay. | ||
| 606 |
_aTOXICODEPENDÊNCIA _9225048 |
||
| 606 |
_aCOMBATE À DROGA _9410441 |
||
| 606 |
_aPOLÍTICA CRIMINAL _9231088 |
||
| 606 |
_aPOLÍTICA COMUNITÁRIA _9232791 |
||
| 606 |
_aREPÚBLICA CHECA _9333273 |
||
| 606 |
_aALEMANHA _9333241 |
||
| 606 |
_aESPANHA _9330771 |
||
| 606 |
_aPAÍSES BAIXOS _9339645 |
||
| 606 |
_aPOLÓNIA _9333222 |
||
| 606 |
_aSUÉCIA _9334325 |
||
| 606 |
_aSUÍÇA _9336290 |
||
| 606 |
_aESTADOS UNIDOS _9334103 |
||
| 606 |
_aURUGUAI _9333590 |
||
| 710 |
_aA REVIEW AND ASSESSMENT OF EU DRUG POLICY _9358316 |
||
| 955 | _xOferta | ||